Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
| Revenue (Most Recent Fiscal Year) | $11.70M |
| Net Income (Most Recent Fiscal Year) | $-50.04M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.02 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -428.37% |
| Net Margin (Trailing 12 Months) | -451.20% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -184.45% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.71 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.62 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 2.92 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-2.24 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.37 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.15 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.34 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 25.21M |
| Free Float | 14.22M |
| Market Capitalization | $0.25M |
| Average Volume (Last 20 Days) | 5.67M |
| Beta (Past 60 Months) | -0.09 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 43.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 17.14% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |